SEC Form 4 · accession 0001493152-16-008093
Ernexa Therapeutics Inc. · ERNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Allen Wolff
Officer — CFO and EVP
Period of report
Mar 16, 2016
Accepted (ET)
Mar 16, 2016 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000748592
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 16, 2016 | P | 5,000 | $0.1828 | A | 70,500 | D | |
| Common StockF1 | Mar 16, 2016 | P | 5,000 | $0.1864 | A | 75,500 | I | See Footnote |
| Common StockF2 | Mar 16, 2016 | P | 5,000 | $0.185 | A | 80,500 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1As custodian of Minor Child 1.
- F2As custodian of Minor Child 2.